Impact of Oral Chemotherapy Management Program on Capecitabine Toxicity Management.
Salin NheanDiana KostoffJessica J YangVishnuprabha VogelIgor I RybkinPublished in: JCO oncology practice (2021)
Most patients who developed capecitabine-related AE required intervention by OCMP. Implementation of OCMP reduced the incidence of high-grade AE, decreased the number of ED visits and hospitalizations because of AE, and improved the medication adherence rate.